Riskpilot← Back to searchSign inGet full accessTrivitalis AB
ABActiveOrg 5569143265Lokattsbacken 56 Lgh 1102General medical practice activities · NACE 8621Est. 20121 employees
Revenue 2025
SEK 2,2M
EBITDA margin
87.5%
+7971% vs 2024
Equity ratio
40.0%
Financial strength
Net profit 2025
SEK 970K
+20% vs 2024
| Revenue | SEK 2,2M | — |
| EBITDA | SEK 1,9M | +7971% |
| Net profit | SEK 970K | +20% |
| Total assets | SEK 10,9M | +416% |
| Equity | SEK 4,3M | +111% |
| Employees | 1 | — |
Legal name
Trivitalis AB
Org number
5569143265
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 december 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är häls- och sjukvård, utbildningsverksamhet samt tv och filmproduktion samt bedriva förvaltning av värdepapper och därmed förenlig verksamhet.
Address
Lokattsbacken 56 Lgh 1102
Email
dag.strom@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | — | — | — | 2 165 |
| Staff expenses | — | — | — | — | 357 |
| EBITDA | −24 | −26 | −28 | −24 | 1 895 |
| Depreciation & amort. | −0 | — | — | — | −6 |
| EBIT | −24 | −26 | −28 | −24 | 1 889 |
| Net financials | −1 | 1 | 298 | 810 | −594 |
| Profit before tax | 2 | 6 | 307 | 809 | 1 269 |
| Tax | −0 | — | — | — | −299 |
| Net profit | 2 | 6 | 307 | 809 | 970 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 438 | 2 019 | 1 928 | 2 106 | 10 859 |
| Equity | 2 272 | 1 999 | 1 903 | 2 065 | 4 347 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 166 | 20 | 25 | 41 | 1 762 |
| Total debt | 166 | 20 | 25 | 41 | 1 762 |
EBITDA margin
87.5%
This company
15.8%
Market median
+454% vs market
20212025
Equity ratio
40.0%
This company
38.2%
Market median
+5% vs market
20212025
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20212025
Net profit margin
44.8%
This company
8.1%
Market median
+453% vs market
20212025
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20212025
Debt / equity
1.50×
This company
0.62×
Market median
-142% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PD Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
JÅ | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Trivitalis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Åke Mikael Ejnarsson | Audit | 0 companies |
| Per David Algot Persson | Chief Auditor | 0 companies |
| Benjamin Karl Emil Ström | Deputy Board Member | 0 companies |
| Dag Owe Emanuel Ström | Board of Directors | 0 companies |